This Week at FDA: New proposed rules, Biocon's Form 483, and more

Regulatory NewsRegulatory NewsBiologics/ biosimilars/ vaccinesBiotechnologyMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy